Home / Fact sheets / Peru / Cervical qualitative data
Check also the following factsheets: Peru, Breast, Colorectal
Country fact sheet: Peru
CERVICAL CANCER SCREENING PROGRAMME
| Reporting year for qualitative data: | 2020 |
| Source of qualitative data: | Directly from Programme |
Organization of screening | |
| An individual/team/institution responsible to coordinate the programme: | Yes |
| Dedicated budget for screening programme: | Yes |
| Documented cancer screening policy: | Yes |
| Nature of documentation of the policy: | Notification |
| Year programme was initiated: | 1990 |
| Programme introduction was preceded by a pilot: | No |
| Screening tests provided free of charge: | Yes |
| Diagnostic tests provided free of charge: | Yes |
| Treatment services provided free of charge: | Yes |
Information system and data collection | |
| System that collects data: | Individual & Aggregated |
| • Identification of eligible population: | Individual |
| • Screening participation: | Individual & Aggregated |
| • Screening test results: | Individual & Aggregated |
| • Further assessment: | Individual & Aggregated |
| • Final pathology diagnosis: | Individual & Aggregated |
| • Cancer staging: | Individual & Aggregated |
| • Treatment: | Individual & Aggregated |
| The information system exists at national or sub-national level: | Individual: Both national and sub-national Aggregated: Both national and sub-national |
| The information system collects data outside the programme (opportunistic screening/private sector): | No |
| Cancer screening data is linked with population-based cancer registry (PBCR): | No |
Screening protocol | |
| A screening protocol or guideline: | Yes |
| Year of published/updated protocol: | 2019 |
| Target age (min-max) and screening interval [months] for each test: | VIA (30-49 years / [24 months]) Cytology (25-64 years / [24 months]) HPV (30-49 years / [60 months]) |
| Triaging test used: | None |
| Self-collection HPV recommended: | Yes |
| "Screen and treat" included in the protocol: | Yes |
| Treatment modality for "screen and treat": | Thermal ablation Cryotherapy LLETZ/CKC |
Invitations for screening and further assessment | |
| Initiatives to create population awareness by the Health Ministry/Health Authority: | Mass media campaign Small media campaign Group education |
| Invitations to eligible population: | No |
| Source of the eligible individuals identified: | - |
| Method of invitation: | - |
| Screening kit included with the invitation: | - |
| Screen positive individuals actively contacted for further assessment: | No |
| Individuals with a precancer or cancer diagnosis actively contacted: | No |
Quality Assurance (QA) of screening activities | |
| Documented standard operating procedure/policy for QA: | Yes |
| An individual/team/institution responsible for QA: | Yes |
| Accreditation of lab services: | No |
| Accreditation of pathology services: | Yes |
| Documented performance indicators: | Yes |
| Reference standards for performance indicators: | Yes |
| Evaluation reports published in the last five years: | No |
Performance indicators | |
| Reporting year for quantitative data: | No data currently available |
Check also the following factsheets: Peru, Breast, Colorectal